Inogen Inc Common Stock
INGNUnited States
5 filed reports · 296 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 1,045 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 861 | Dec 2025 |
Financial data
296 concepts · 1,906 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial293 concepts · 1,877 facts · Dec 2022 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents including disposal group and discontinued operations15 · Dec 2022 to Jun 2026
- Stockholders equity (US GAAP)15 · Dec 2022 to Jun 2026
- Cash and cash equivalents at carrying value13 · Dec 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents13 · Dec 2023 to Jun 2026
- Number of contract ineffective hedges13 · Dec 2023 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value12 · Dec 2023 to Jun 2026
- Allocated share based compensation expense12 · Dec 2023 to Jun 2026
- Comprehensive income net of tax12 · Dec 2023 to Jun 2026
- Cost of goods and services sold depreciation12 · Dec 2023 to Jun 2026
- Cost of goods and services sold (US GAAP)12 · Dec 2023 to Jun 2026
- Cost of property repairs and maintenance12 · Dec 2023 to Jun 2026
- Cost of rental revenue, including depreciation of $3,017 and $3,128, for the three months ended and $6,051 and $6,307 for the six months ended, respectively12 · Dec 2023 to Jun 2026
- Cost of revenue (US GAAP)12 · Dec 2023 to Jun 2026
- Depreciation and amortization12 · Dec 2023 to Jun 2026
- General and administrative expense (US GAAP)12 · Dec 2023 to Jun 2026
- Gross profit-rental revenue12 · Dec 2023 to Jun 2026
- Gross profit-sales revenue12 · Dec 2023 to Jun 2026
- Gross profit (US GAAP)12 · Dec 2023 to Jun 2026
- Income tax expense benefit12 · Dec 2023 to Jun 2026
- Incremental common shares attributable to share based payment arrangements12 · Dec 2023 to Jun 2026
- Investment income interest12 · Dec 2023 to Jun 2026
- Net income loss12 · Dec 2023 to Jun 2026
- Nonoperating income expense12 · Dec 2023 to Jun 2026
- Operating expenses (US GAAP)12 · Dec 2023 to Jun 2026
Geography3 concepts · 29 facts · Dec 2023 to Jun 2026
- Revenue24 · Dec 2023 to Jun 2026
- Revenue from contracts with customers (excluding tax)3 · Dec 2023 to Dec 2025
- Operates medical technology and home medical equipment in number of states2 · Mar 2026 to Jun 2026
Segments
29 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement geographical2 members · 29 facts
- US17 · Dec 2023 to Jun 2026
- Non Us12 · Dec 2023 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Nov 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
- FY2026 Q1May 8, 2026
- FY2025 Q4Feb 24, 2026
- FY2025 Q3Nov 5, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.